CRDL · Cardiol Therapeutics Inc. · Documents
Market Cap
$139.74M
Shares
121.51M
Volume · Oct 21
617.28K
Avg daily vol (3M)
1.4M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 40-F | — | 2025-03-31 | 2024-12-31 | |
| 6-K | — | 2025-03-14 | — | |
| 6-K | — | 2025-03-03 | — | |
| 6-K | — | 2025-02-20 | — | |
| 6-K | — | 2025-02-04 | — | |
| 6-K | — | 2024-11-18 | — | |
| 6-K | — | 2024-11-14 | 2024-09-30 | |
| 6-K | — | 2024-10-22 | — | |
| 6-K | — | 2024-10-11 | — | |
| 6-K | — | 2024-10-10 | — | |
| 6-K | — | 2024-10-09 | — | |
| 6-K | — | 2024-10-08 | — | |
| 6-K | — | 2024-09-24 | — | |
| 6-K | — | 2024-09-10 | — | |
| 6-K | — | 2024-08-12 | 2024-06-30 | |
| 6-K | — | 2024-07-16 | — | |
| 6-K | — | 2024-06-27 | — | |
| 6-K | — | 2024-06-25 | — | |
| 6-K | — | 2024-06-13 | — | |
| 6-K | — | 2024-05-28 | 2023-12-31 | |
| 6-K | — | 2024-05-14 | 2024-03-31 | |
| 6-K | — | 2024-05-14 | — | |
| 6-K | — | 2024-04-26 | 2024-04-18 | |
| 6-K | — | 2024-04-02 | — | |
| 20-F | — | 2024-04-01 | 2023-12-31 | |
| 6-K | — | 2024-02-26 | — | |
| 6-K | — | 2024-02-21 | — | |
| 6-K | — | 2024-02-15 | — | |
| 6-K | — | 2024-01-24 | — | |
| 6-K | — | 2024-01-09 | — | |
| 6-K | — | 2023-12-05 | — | |
| 6-K | — | 2023-11-16 | — | |
| 6-K | — | 2023-11-14 | 2023-09-30 | |
| 6-K | — | 2023-11-01 | — | |
| 6-K | — | 2023-10-20 | — | |
| 6-K | — | 2023-10-11 | — | |
| 6-K | — | 2023-10-10 | — | |
| 6-K | — | 2023-09-26 | — | |
| 6-K | — | 2023-09-20 | — | |
| 6-K | — | 2023-09-19 | — | |
| 6-K | — | 2023-08-10 | 2023-06-30 | |
| 6-K | — | 2023-08-09 | — | |
| 6-K | — | 2023-08-08 | — | |
| 6-K | — | 2023-06-29 | — | |
| 6-K | — | 2023-06-27 | — | |
| 6-K | — | 2023-05-18 | 2023-06-28 | |
| 6-K | — | 2023-05-15 | 2023-03-31 | |
| 6-K | — | 2023-03-29 | — | |
| 20-F | — | 2023-03-29 | 2022-12-31 | |
| 6-K | — | 2023-03-07 | — |
Showing 51–100 of 140 filings